Laddar...
T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY
BACKGROUND: Approximately 30% of patients with schizophrenia do not respond to antipsychotics and are thus considered to have treatment-resistant schizophrenia (TRS). To date, only four studies have examined glutamatergic neurometabolite levels using proton magnetic resonance spectroscopy (1H-MRS) i...
Sparad:
| I publikationen: | Schizophr Bull |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7234367/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbaa029.772 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|